0001239241-13-000007.txt : 20130925 0001239241-13-000007.hdr.sgml : 20130925 20130925184810 ACCESSION NUMBER: 0001239241-13-000007 CONFORMED SUBMISSION TYPE: 3/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20130918 FILED AS OF DATE: 20130925 DATE AS OF CHANGE: 20130925 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ACCELERON PHARMA INC CENTRAL INDEX KEY: 0001280600 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 128 SYDNEY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 617-649-9200 MAIL ADDRESS: STREET 1: 128 SYDNEY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: EVNIN ANTHONY B CENTRAL INDEX KEY: 0001239241 FILING VALUES: FORM TYPE: 3/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-36065 FILM NUMBER: 131115331 MAIL ADDRESS: STREET 1: C/O VENROCK ASSOCIATES STREET 2: 30 ROCKEFELLER PLAZA RM 5508 CITY: NEW YORK STATE: NY ZIP: 21264957 3/A 1 edgar.xml PRIMARY DOCUMENT X0206 3/A 2013-09-18 2013-09-18 0 0001280600 ACCELERON PHARMA INC XLRN 0001239241 EVNIN ANTHONY B C/O VENROCK 530 FIFTH AVENUE, 22ND FLOOR NEW YORK NY 10036 1 0 1 0 Series E Convertible Preferred Stock Common Stock 118240 I By Funds The Series A Convertible Preferred Stock, Series B Convertible Preferred Stock, Series C Convertible Preferred Stock, Series D Convertible Preferred Stock, Series E Convertible Preferred Stock and Series F Convertible Preferred Stock are each convertible into Common Stock at any time at the holder's election and upon the consummation of a qualified public offering of the registrant. There is no expiration date for any series of convertible preferred stock. Consists of an aggregate of 96,248 shares of Series E Convertible Preferred Stock ("Series E Stock") held by Venrock Associates IV, L.P. ("Venrock IV"), 19,628 shares of Series E Stock held by Venrock Partners, L.P. ("Venrock Partners"), and 2,364 shares of Series E Stock held by Venrock Entrepreneurs Fund IV, L.P. ("Venrock Entrepreneurs" and together with Venrock IV and Venrock Partners, the "Venrock Entities"). The sole general partner of Venrock IV is Venrock Management IV, LLC ("VM4"). The sole general partner of Venrock Partners is Venrock Partners Management, LLC ("VPM"). The sole general partner of Venrock Entrepreneurs is VEF Management IV, LLC ("VEFM4"). VM4, VPM and VEFM4 disclaim beneficial ownership over all shares held by the Venrock Entities, except to the extent of their indirect pecuniary interests therein. Anthony B. Evnin is a member of VM4, VPM and VEFM4 and as such, he may be deemed to have voting and investment power with respect to these shares. Dr. Evnin disclaims beneficial ownership of these shares except to the extent of his indirect pecuniary interest therein. /s/ Anthony B. Evnin 2013-09-25